PROK,ProKidney Corp. | Healthcare

Healthcare

PROK

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

ProKidney Corp.PROK

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases.

The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture that is in Phase I for REACT in patients with Congenital Anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease.

ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Latest News >

House of Doge Congratulates Partner 21Shares on Acquisition by FalconX

Oct 23, 2025

MIAMI, Oct. 23, 2025 (GLOBE NEWSWIRE) -- House of Doge Inc., the official corporate arm of the Dogecoin Foundation, congratulates 21Shares, the world’s leading provider of cryptocurrency exchange-traded products, on its announced acquisition by FalconX. The transaction represents a significant step in the effort to align listed markets with digital assets and expands FalconX’s global presence across the United States,...

Update: Blackstone Shares Fall After Q3 Revenue Miss

Oct 23, 2025

10:14 AM EDT, 10/23/2025 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Blackstone (BX) shares fell nearly 5% in recent Thursday trading after the company posted lower-than-expected Q3 revenue. The company reported Q3 distributable earnings Thursday of $1.52 per share, up from $1.01 a year earlier. Analysts polled by FactSet expected...

Southwest Airlines Surprises With Profit, Expects Momentum To Continue Into Q4

Oct 23, 2025

Southwest Airlines Company ( LUV ) shares are trading higher on Thursday after the company reported third-quarter FY25 results on Wednesday. Details The company reported adjusted earnings of 11 cents per share, which exceeded the Street consensus estimate of a loss of 3 cents per share. Quarterly revenue also came in below expectations at $6.95 billion, exceeding the $6.92 billion analyst estimate. Also Read: Airports Reject...

Market Chatter: Google Signs Power Offtake Deal With Planned US Carbon Capture Plant

Oct 23, 2025

10:13 AM EDT, 10/23/2025 (MT Newswires) -- Alphabet's (GOOGL, GOOG) Google ( GOOG ) has signed an agreement to purchase electricity from a proposed power plant that will use carbon capture and storage, Reuters reported Thursday, citing the technology company. The 400-megawatt power plant in Decatur, Illinois, is expected to be operational in early 2030s, and will produce power by...